World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33490747

Number of visits today: 1158

Number of downloads: 16680272

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Lombardi F, Augello FR, Artone S, Gugu MK, Cifone MG, Cinque B, Palumbo P. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines. Int J Mol Sci 2022;23:1545. [PMID: 35163465 DOI: 10.3390/ijms23031545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Lombardi F, Augello FR, Artone S, Gugu MK, Cifone MG, Cinque B, Palumbo P. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines. Int J Mol Sci 2022;23:1545. [PMID: 35163465 DOI: 10.3390/ijms23031545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	Di Nunno V, Aprile M, Gatto L, Tosoni A, Ranieri L, Bartolini S, Franceschi E. Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab? Cancers (Basel) 2023;15. [PMID: 36831383 DOI: 10.3390/cancers15041042] [Reference Citation Analysis]
2	Sharma A, Guerrero-Cázares H, Maciaczyk J. Editorial to Special Issue "Glioblastoma: Recapitulating the Key Breakthroughs and Future Perspective". Int J Mol Sci 2023;24. [PMID: 36768870 DOI: 10.3390/ijms24032548] [Reference Citation Analysis]
3	Lombardi F, Augello FR, Artone S, Ayroldi E, Giusti I, Dolo V, Cifone MG, Cinque B, Palumbo P. Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype. Front Oncol 2022;12:933746. [DOI: 10.3389/fonc.2022.933746] [Reference Citation Analysis]
4	Yang J, Lee I, Chen C, Lu F, Chung C, Lee M, Cheng Y, Chen K, Peng J, Chen C. Gallic Acid Enhances the Anti-Cancer Effect of Temozolomide in Human Glioma Cell Line via Inhibition of Akt and p38-MAPK Pathway. Processes 2022;10:448. [DOI: 10.3390/pr10030448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]